Related posts
The Ultimate Top Drone Stocks List for Sky-High Returns (25+ Stocks)2 Stocks on Sale: CAE and PaypalU.S. stocks climb on Fed minutes, TSX weakens on oilThis summary was created by AI, based on 2 opinions in the last 12 months.
L3Harris Technologies (LHX-N) is a defense contractor that is currently trading at a low PE ratio of 14x for 2024, according to one expert. Another expert sees a potential for growth due to LHX's high-tech military products that the government desires, making it undervalued at a 15x PE ratio. Overall, the company is viewed positively for its position in the defense technology market.
Is seeing an amazing decline. LHX makes exactly the high tech that the government wants all its military to adopt. At 15x PE, it's too cheap.
L3Harris Technologies is a American stock, trading under the symbol LHX-N on the New York Stock Exchange (LHX). It is usually referred to as NYSE:LHX or LHX-N
In the last year, 1 stock analyst published opinions about LHX-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for L3Harris Technologies.
L3Harris Technologies was recommended as a Top Pick by on . Read the latest stock experts ratings for L3Harris Technologies.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered L3Harris Technologies In the last year. It is a trending stock that is worth watching.
On 2024-10-29, L3Harris Technologies (LHX-N) stock closed at a price of $245.12.
Another Trump-tech trade. Defense technology provider. From tactical radios to applications to hardware. Also involved in space and aerospace, and you'll find that LHX is the leader in ETFs that cover that sector. 12-month price target of $273. Buy a third here around $240, add in the mid-$220s, and again at the $215 level. Reports next week. Yield is 1.9%.
(Analysts’ price target is $248.82)